Anxiety: End of Life

Jump to
Abstracts Focused Research Topics

Focus Your Research

Click any topic below to filter + focus research

4 Substances Researched for Anxiety: End of Life

Name	AC	CK
Psilocybin	5	33
Lysergic Acid Diethylamide (LSD)	3	12
Bitter Orange	1	10
Psychedelics:All	3	3

1 Therapeutic Actions Researched for Anxiety: End of Life

Name	AC	CK	Focus
Aromatherapy	1	10

Research Articles 8
Cumulative Knowledge Score 12
Overall Research Rating GOOD

View the Evidence:
8 Abstracts with Anxiety: End of Life Research

Filter by Study Type

Sort Abstracts

Limited to Members Only

By default, all articles on GreenMedInfo.com are sorted based on the content type which best reflects the data which most users are searching for. For instance, people viewing substances are generally most interested in viewing diseases that these substances have shown to have positive influences. This section is for allowing more advanced sorting methods. Currently, these advanced sorting methods are available for members only. If you are already a member, you can sign in by clicking here. If you do not currently have a user account, and would like to create one/become a member, click here to begin the singup process.

Currently Available Sorting Options

Article Published Date - Sort all displayed articles by their published date
Quick Summary Fieldsets - Sort alphabetically, rather than by Cumulative Knowledge
Cumulative Knowledge - Default sorting method. Allows you to sort descendingly

Free Sample of Member-Only Features

Although all 30,000+ articles on GreenMedInfo.com are made entirely free to view as an educational service to the public, we provide a powerful set of enhanced data comprehension and retrieval tools for subscribing members. Above you are viewing a free preview, limited to 10000 rows, of the membership feature called "Cumulative Knowledge" (learn more).

The Focus Article Feature is not enabled.

Upgrading to the Friend membership gives you access to unlimited rows of Cumulative Knowledge data.

To Participate

Click here to login
Click here to order a membership

[+]

Psilocybin as a new approach to treat depression and anxiety in the context of life-threatening diseases.Sep 04, 2020

Click here to read the entire abstract

Article Publish Status : This is a free article. Click here to read the complete article.

Pubmed Data : Biomedicines. 2020 Sep 5 ;8(9). Epub 2020 Sep 5. PMID: 32899469

Article Published Date : Sep 04, 2020

Study Type : Meta Analysis, Review

Additional Links

Substances : Psilocybin

Diseases : Anxiety, Anxiety: End of Life, Depression

Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents

[+]

C. aurantium exhibits an anxiolytic effect and reduces the signs and symptoms associated with anxiety in patients with chronic myeloid leukemia.Mar 31, 2016

Click here to read the entire abstract

Pubmed Data : Phytother Res. 2016 Apr ;30(4):613-7. Epub 2016 Jan 20. PMID: 26787366

Article Published Date : Mar 31, 2016

Study Type : Human Study

Additional Links

Substances : Bitter Orange

Diseases : Anxiety: End of Life

Therapeutic Actions : Aromatherapy

Pharmacological Actions : Anti-Anxiety Agents

Additional Keywords : Essential Oils

[+]

LSD administered in a medically supervised psychotherapeutic setting can be safe and generate lasting benefits in patients with a life-threatening disease.Dec 31, 2014

Click here to read the entire abstract

Pubmed Data : J Psychopharmacol. 2015 Jan ;29(1):57-68. Epub 2014 Nov 11. PMID: 25389218

Article Published Date : Dec 31, 2014

Study Type : Human Study

Additional Links

Substances : Lysergic Acid Diethylamide (LSD)

Diseases : Anxiety: End of Life, Cancers: All, Quality of Life: Poor

Pharmacological Actions : Anti-Anxiety Agents

Additional Keywords : Significant Treatment Outcome

[+]

These findings suggest that psilocybin-assisted psychotherapy holds promise in promoting long-term relief from cancer-related psychiatric distress.Jan 31, 2020

Click here to read the entire abstract

Pubmed Data : J Psychopharmacol. 2020 Feb ;34(2):155-166. Epub 2020 Jan 9. PMID: 31916890

Article Published Date : Jan 31, 2020

Study Type : Human Study

Additional Links

Substances : Psilocybin

Diseases : Anxiety: End of Life, Cancers: Psychological Stress

Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents

[+]

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.Apr 30, 2019

Click here to read the entire abstract

Pubmed Data : Pharmacol Ther. 2019 May ;197:83-102. Epub 2018 Dec 4. PMID: 30521880

Article Published Date : Apr 30, 2019

Study Type : Review

Additional Links

Substances : Lysergic Acid Diethylamide (LSD), Psilocybin, Psychedelics:All

Diseases : Alcohol Addiction, Anxiety: End of Life, Depression

Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents

Additional Keywords : Spiritual Experiences

[+]

Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.Nov 28, 2019

Click here to read the entire abstract

Pubmed Data : Psychopharmacology (Berl). 2019 Nov 29. Epub 2019 Nov 29. PMID: 31784805

Article Published Date : Nov 28, 2019

Study Type : Review

Additional Links

Substances : Lysergic Acid Diethylamide (LSD), Psilocybin, Psychedelics:All

Diseases : Anxiety: End of Life

Pharmacological Actions : Anti-Anxiety Agents

[+]

Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.Jan 27, 2019

Click here to read the entire abstract

Article Publish Status : This is a free article. Click here to read the complete article.

Pubmed Data : BMC Psychiatry. 2019 10 28 ;19(1):321. Epub 2019 Oct 28. PMID: 31660905

Article Published Date : Jan 27, 2019

Study Type : Commentary

Additional Links

Substances : Psychedelics:All

Diseases : Anxiety: End of Life, Cancers: All

Pharmacological Actions : Anti-Anxiety Agents

[+]

This review will explore the potential of psilocybin in the treatment of neuropsychiatry-related conditions.May 14, 2021

Click here to read the entire abstract

Article Publish Status : This is a free article. Click here to read the complete article.

Pubmed Data : Molecules. 2021 May 15 ;26(10). Epub 2021 May 15. PMID: 34063505

Article Published Date : May 14, 2021

Study Type : Review

Additional Links

Substances : Psilocybin

Diseases : Anxiety: End of Life, Cancers: All

Pharmacological Actions : Anti-Anxiety Agents

Research Articles 8
Cumulative Knowledge Score 12
Overall Research Rating GOOD

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

Printer-friendly version

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

Anxiety: End of Life jQuery(function ($) { $(".node-field-image").click(function () { $(".node-field-image").toggleClass("open"); }); $(".node.topic>.colfull").click(function () { $(".node.topic>.colfull").toggleClass("open"); }); })

Focus Your Research

Click any topic below to filter + focus research

View the Evidence: 8 Abstracts with Anxiety: End of Life Research

Limited to Members Only

Currently Available Sorting Options

Psilocybin as a new approach to treat depression and anxiety in the context of life-threatening diseases.Sep 04, 2020

C. aurantium exhibits an anxiolytic effect and reduces the signs and symptoms associated with anxiety in patients with chronic myeloid leukemia.Mar 31, 2016

LSD administered in a medically supervised psychotherapeutic setting can be safe and generate lasting benefits in patients with a life-threatening disease.Dec 31, 2014

These findings suggest that psilocybin-assisted psychotherapy holds promise in promoting long-term relief from cancer-related psychiatric distress.Jan 31, 2020

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.Apr 30, 2019

Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.Nov 28, 2019

Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.Jan 27, 2019

This review will explore the potential of psilocybin in the treatment of neuropsychiatry-related conditions.May 14, 2021

Print Options

Anxiety: End of Life

View the Evidence:
8 Abstracts with Anxiety: End of Life Research